Cipla
AskBiography Logo   Latest News  Follow Us on Twitter  Follow Us on Google Buzz  Became Fan - Facebook  Subscribe to RSSRSS   Bookmark and Share

Cipla

Company nameCIPLA Limited
IndustryPharmaceuticals
Founded1935
HeadquartersMumbai, India
Key peopleY. K. Hamied (CMD), Chairman
Revenue(+) Rs. 37.6 billion (~939M USD) (2006)
Net income(+) Rs. 9.1 billion (2006)
Employeesover 7,000|parent=

     Home | Company | Cipla



Cipla, is a prominent Indian pharmaceutical company, best-known outside its home country for manufacturing low-cost anti-AIDS drugs for HIV-positive patients in developing countries. Founded by Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories, Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions, and its products are distributed in more than 180 countries worldwide. Among the hundreds of generic medications it produces for international distribution are atorvastatin, amlodipine, fluoxetine, venlafaxine hydrochloride and metformin. Recently, Cipla sold the manufacturing rights of its high-end emergency contraceptive pill, I-pill, to its pharma field counterpart Nicholas Piramal (Piramal Healthcare) for Rs. 95 million. Cipla earned a revenue of total Rs. 33 million (approx.) from the sales of their popular contraceptive pill, to date.


Latest News : Cipla : Tweet this RSS

Tata Cap healthcare fund eyes Rs 600 cr investments - Business Standard Tweet this news
Business Standard--This fund, which is starting to find its feet, is spearheaded by Visalakshi Chandramouli, who was with Merrill Lynch and -Cipla- Pharmaceuticals earlier. ... - Date : Thu, 01 Jul 2010 15:59:39 GMT+00:00
Cipla in talks with Centre to share cancer drug know-how - Economic Times Tweet this news
Economic Times--NEW DELHI: Pharma powerhouse -Cipla- has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radically ... - Date : Sun, 27 Jun 2010 21:33:13 GMT+00:00
Nifty above 5300 FMCG oil gas auto infra rise - Moneycontrol.com Tweet this news
Moneycontrol.com--However, Wipro, TCS, Infosys, Bharti, GAIL, SAIL, -Cipla-, Axis Bank and Hero Honda were the losers, which capped the gains to some extent. ... - Date : Wed, 30 Jun 2010 09:41:19 GMT+00:00
Cipla: Move to enter biotech looks opportune - Economic Times Tweet this news
Economic Times---Cipla's- latest move to grow through acquisitions comes at a time when the company has been growing at lower than the industry growth rate for the past few ... - Date : Wed, 16 Jun 2010 19:36:33 GMT+00:00
Sensex Weak; Cipla, RCom, Maruti Firm - TopNews Tweet this news
TopNews--The major gainers in the Sensex pack included -Cipla- (2.23%), RCom (1.99%), Maruti Suzuki (1.36%), RIL (0.81%), BHEL and NTPC. In contrast, the top losers in ... - Date : Fri, 25 Jun 2010 07:39:22 GMT+00:00
After Cipla, Piramal gets into biotech - Daily News & Analysis Tweet this news
Daily News & Analysis--Mumbai: After -Cipla- last week acquired stake into two biotech companies, it's now Piramal Healthcare's turn to foray into the biotechnology sector. ... - Date : Tue, 22 Jun 2010 20:28:52 GMT+00:00
Stocks to watch: Cipla, Cairn, TCS, RIL, Ranbaxy, HUL, SAIL, SBI - Economic Times Tweet this news
Economic Times--MUMBAI: Drug maker -Cipla- on Tuesday said it will acquire significant minority stake in two biotech companies � one each in Goa and Shanghai � for $65 ... - Date : Wed, 16 Jun 2010 04:44:02 GMT+00:00
Cipla FY'10 net profit up by 40% - Stock Watch Tweet this news
Stock Watch--Leading drug maker of the country -Cipla- has announced its year-end financial results for the fiscal year 2009-10 and it has posted an impressive rise in net ... - Date : Sat, 26 Jun 2010 07:56:42 GMT+00:00
Indian pharma majors bet big on biotechnology space - NDTV.com Tweet this news
NDTV.com--This explains the recent investments by pharma majors by -Cipla- and Piramal. -Cipla- has recently approved the acquisition of a 40 per cent stake in Indian ... - Date : Wed, 23 Jun 2010 19:33:39 GMT+00:00
Adcock, Merck team up to promote drugs in S.Africa - Reuters Africa Tweet this news
Reuters Africa--South Africa's second-biggest generic drugs maker, which scrapped a 2 billion rand takeover bid for rival -Cipla- Medpro last year, is looking for new ways to ... - Date : Thu, 24 Jun 2010 06:03:48 GMT+00:00



Privacy | Sitemap